HITGEN
LIVE

Serial Number

79272412

Owner

HitGen Inc.

Attorney

Eric J. Maiers

Filing Date

Apr 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

HITGEN Trademark

Serial Number: 79272412 • Registration: 6150102

HITGEN is a trademark filed by HitGen Inc. on April 11, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HitGen Inc. (6 trademarks)

Floor 3, Building 1, No. 88, Keyuan South Road,

Entity Type: 03

HITGEN LTD. (3 trademarks)

1001, UNIT 3,

Entity Type: 99

Trademark Details

Filing Date

April 11, 2019

Registration Date

September 15, 2020

Published for Opposition

June 30, 2020

Goods & Services

Medicines for human purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemical preparations for medical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease or ophthalmic diseases

Shop window dressing; outdoor advertising; bill-posting; distribution of samples; publicity services

Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical research

Technical project studies, namely, technical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research and development services relating to DNA encoded library synthesis; research and development services relating to DNA encoded library selection; research and development services relating to DNA encoded library data analysis

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 15, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 8, 2023 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 10, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 31, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 30, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 15, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 18, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 18, 2020 TROA
REFUSAL PROCESSED BY IB
Jan 24, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 4, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 4, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 7, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 5, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 4, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 27, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 21, 2019 REPR